The Hindu·3 min read·medium
Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue
T
The Hindu Bureau
✦AI Summary
Gland Pharma reported a 47% increase in net profit for the June quarter, reaching ₹317 crore, driven by strong demand and new product launches. The company also announced a strategic manufacturing partnership to expand its global footprint in sterile injectables.
Injectable-focussed generic drugmaker Gland Pharma reported consolidated net profit for June quarter rose 47% year-on-year (YoY) to ₹317 crore.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in